Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (138) Apply European Commission final decision filter

Referral safety status

Yes (6) Apply Yes filter

Referral type

Article 29(4) referrals Remove Article 29(4) referrals filter Article 20 procedures Remove Article 20 procedures filter Article 31 referrals (115) Apply Article 31 referrals filter Article 30 referrals (95) Apply Article 30 referrals filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 107i procedures (8) Apply Article 107i procedures filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (18) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (20) Apply Centrally authorised product(s) filter Nationally authorised product(s) (9) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (2) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

138 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral type Article 20 procedures Remove Article 20 procedures filter Article 29(4) referrals Remove Article 29(4) referrals filter

Sort by

List item

Referral: Zinbryta

daclizumab, associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, EC decision date: 27/03/2018, Last updated: 11/07/2018
List item

Referral: Picato

ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020
List item

Referral: Actilyse

Alteplase, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 30/09/2002, Last updated: 25/01/2006
List item

Referral: Adartrel

Ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006
List item

Referral: Aggrastat

Tirofiban, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/03/1999, EC decision date: 18/06/1999, Last updated: 18/06/1999
List item

Referral: Alcover and associated names

sodium oxybate, associated names: n/a, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 18/12/2017, Last updated: 12/01/2018
List item

Referral: Alendronate HEXAL

alendronic acid (as sodium alendronate trihydrate), Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/01/2007, EC decision date: 13/04/2007, Last updated: 20/08/2007
List item

Referral: Alvesco

ciclesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 11/07/2008, Last updated: 05/08/2008
List item

Referral: Amaryl

Glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998
List item

Referral: Amlodipin Woerwag

Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 27/04/2004, Last updated: 30/06/2004
List item

Referral: Amlovita

Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 26/04/2004, Last updated: 26/04/2004
List item

Referral: Avalox

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013
List item

Referral: Betavert N

betahistine dihydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2009, EC decision date: 02/06/2009, Last updated: 01/07/2007
List item

Referral: Bicaluplex

bicalutamide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 22/11/2007, Last updated: 07/02/2008
List item

Referral: Bleomycin

bleomycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 31/03/2009
List item

Referral: Budesonide Sandoz

budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/02/2009, EC decision date: 07/05/2009, Last updated: 25/06/2009
List item

Referral: Budesonide SUN

budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2020, EC decision date: 19/08/2020, Last updated: 16/09/2020
List item

Referral: Canazole

clotrimazole, associated names: Canesten, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 22/09/2011, Last updated: 09/02/2012
List item

Referral: Carbamazepin Tillomed

carbamazepin, associated names: Carbamazepin Tillomed, Carbamazepina Tillomed, Karbamazepin Tillomed, Karbamazepina Tillomed, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 25/06/2020, Last updated: 21/07/2020
List item

Referral: Cardoreg 4mg

Doxazosin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/06/2006, EC decision date: 11/10/2006, Last updated: 11/10/2006
List item

Referral: Ceftriaxone Tyrol Pharma

Ceftriaxone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, Last updated: 30/08/2006
List item

Referral: Ciclosporin IDL

ciclosporin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 22/07/2010, Last updated: 20/11/2013
List item

Referral: Ciprofloxacin Hikma

ciprofloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/01/2007, EC decision date: 11/06/2007, Last updated: 06/09/2007
List item

Referral: Ciprofloxacin Kabi

Ciprofloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/11/2006, EC decision date: 24/01/2007, Last updated: 06/02/2007
List item

Referral: Ciprofloxacin Nycomed

Ciprofloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/11/2006, EC decision date: 18/01/2008, Last updated: 18/02/2008

Load more

138 results

Referral: Zinbryta

Referral: Picato

Referral: Actilyse

Referral: Adartrel

Referral: Aggrastat

Referral: Alcover and associated names

Referral: Alendronate HEXAL

Referral: Alvesco

Referral: Amaryl

Referral: Amlodipin Woerwag

Referral: Amlovita

Referral: Avalox

Referral: Betavert N

Referral: Bicaluplex

Referral: Bleomycin

Referral: Budesonide Sandoz

Referral: Budesonide SUN

Referral: Canazole

Referral: Carbamazepin Tillomed

Referral: Cardoreg 4mg

Referral: Ceftriaxone Tyrol Pharma

Referral: Ciclosporin IDL

Referral: Ciprofloxacin Hikma

Referral: Ciprofloxacin Kabi

Referral: Ciprofloxacin Nycomed